drugset
drugset / Trial / NCT02557126

Study of URC102 to Assess the Safety and Efficacy in Gout Patients

NCT02557126 ↗

Phase 2 Completed 76 enrolled JW Pharmaceutical
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess safety, Pharmacokinetics/Pharmacodynamics and Urate Lowering Effect of URC102 in gout patients.

Timeline

Start
2015-10
Primary completion
2016-08
Completion
2016-08

Drugs

EvaluationDrugModalityDoseRoute
Subject URC102 Unknown — —

Indications

gout